MedTrace Logo

Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat

NCT00012168 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2016-03-11

No results posted yet for this study

Summary

RATIONALE: New imaging procedures such as lymphoscintigraphy may improve the ability to detect the spread of mouth and throat cancer to lymph nodes in the neck.

PURPOSE: Pilot study of lymphoscintigraphy followed by sentinel lymph node mapping and sentinel lymph node biopsy to detect lymph node metastases in the neck in patients who have mouth or throat cancer.

Conditions

Interventions

DRUG

isosulfan blue

GENETIC

polymerase chain reaction

OTHER

immunohistochemistry staining method

PROCEDURE

lymphangiography

PROCEDURE

radionuclide imaging

PROCEDURE

sentinel lymph node biopsy

RADIATION

technetium Tc 99m sulfur colloid

Sponsors & Collaborators

Principal Investigators

  • Moni A. Kuriakose, MD · NYU Langone Health

Study Design

Purpose
DIAGNOSTIC

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-05-31
Primary Completion
2003-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00012168 on ClinicalTrials.gov